← Leaderboards
Mei X Wu
Massachusetts General Hospital
$13,491,815
Attributed
$13,603,631
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,603,631 · 16
By mechanism
R01$8,179,515 · 5
R21$3,114,279 · 7
RC1$997,452 · 1
R56$558,202 · 1
K02$530,550 · 1
R41$223,633 · 1
Top collaborators
- Xinmin Simon Xie1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Lisa M Bebell$4,084,300
- Thorsten Roman Mempel$17,082,637
- Xinyuan Chen$4,097,118
- Dai Fukumura$13,639,390
- Gavin Peter Dunn$4,424,470
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantImmune ResponseMediatingBaseCessation Of LifeVaccinesCellsAntigensDosePreventVaccinationImmunizationProductionAntigen-Presenting CellsSkinInvestigationInfluenza Virus VaccineAreaTechnologyImmunityProteinsLasersInfluenzaResponse
Grant awards (41)
Spatial and Temporal Adjuvant Delivery for Skin mRNA Vaccination$676,666
R01 · FY2025 · AI · contact PI
A new mucosal adjuvant for augmenting influenza vaccines in elderly$394,125
R01 · FY2025 · AI · contact PI
A novel bacteria-specific pro-photosensitizer$248,148
R21 · FY2025 · AI · contact PI
A new mucosal adjuvant for augmenting influenza vaccines in elderly$546,487
R01 · FY2024 · AI · contact PI
A novel bacteria-specific pro-photosensitizer$208,410
R21 · FY2024 · AI · contact PI
Biomimetic nanoparticles to enhance the breadth of influenza vaccines$1
R01 · FY2024 · AI · contact PI
Biomimetic nanoparticles to enhance the breadth of influenza vaccines$562,273
R01 · FY2023 · AI · contact PI
A new mucosal adjuvant for augmenting influenza vaccines in elderly$464,034
R01 · FY2022 · AI · contact PI
Biomimetic nanoparticles to enhance the breadth of influenza vaccines$500,250
R01 · FY2021 · AI · contact PI
A new mucosal adjuvant for augmenting influenza vaccines in elderly$482,747
R01 · FY2021 · AI · contact PI
Delivery of Powdered Vaccines for Improving Newborn Vaccination$247,328
R21 · FY2021 · AI · contact PI
Biomimetic nanoparticles to enhance the breadth of influenza vaccines$445,294
R01 · FY2020 · AI · contact PI
Delivery of Powdered Vaccines for Improving Newborn Vaccination$209,229
R21 · FY2020 · AI · contact PI
Biomimetic nanoparticles for augmenting influenza vaccines in elderly$558,202
R56 · FY2019 · AI · contact PI
Potentials of a Newly Engineered Device for Treatment of Neonatal Thrombocytopenia$245,957
R21 · FY2019 · HL · contact PI
Delivery of Peanut Allergen Powder into Epidermis for Safe Immunotherapy$206,173
R21 · FY2019 · AI · contact PI
Delivery of Peanut Allergen Powder into Epidermis for Safe Immunotherapy$247,476
R21 · FY2018 · AI · contact PI
Potentials of a Newly Engineered Device for Treatment of Neonatal Thrombocytopenia$211,574
R21 · FY2018 · HL · contact PI
Sample-free onsite detection of cocaine using microneedles via laser-treated skin$223,633
R41 · FY2016 · DA
Boosting Flu Vaccination without Adjuvant Injection$717,661
R01 · FY2015 · AI · contact PI
Laser-facilitated powder-allergen delivery for epicutaneous immunotherapy$212,705
R21 · FY2015 · AI · contact PI
Boosting Flu Vaccination without Adjuvant Injection$603,518
R01 · FY2014 · AI · contact PI
Laser-facilitated powder-allergen delivery for epicutaneous immunotherapy$252,209
R21 · FY2014 · AI · contact PI
Boosting Flu Vaccination without Adjuvant Injection$444,655
R01 · FY2013 · AI · contact PI
Laser-facilitated delivery of malarial sporozoites from the skin to liver$234,906
R21 · FY2013 · AI · contact PI
Boosting Flu Vaccination without Adjuvant Injection$467,323
R01 · FY2012 · AI · contact PI
Laser-facilitated delivery of malarial sporozoites from the skin to liver$212,244
R21 · FY2012 · AI · contact PI
IEX-1 as a potential biomarker for early detection of myelodysplastic syndromes$172,391
R21 · FY2012 · CA · contact PI
Boosting Flu Vaccination without Adjuvant Injection$526,515
R01 · FY2011 · AI · contact PI
IEX-1 as a potential biomarker for early detection of myelodysplastic syndromes$205,529
R21 · FY2011 · CA · contact PI
Laser Adjuvant for Nicotine Vaccines$497,891
RC1 · FY2010 · DA · contact PI
IEX-1 in bridge of innate to adaptive immune responses to memory T cells$106,110
K02 · FY2010 · AI · contact PI
Laser Adjuvant for Nicotine Vaccines$499,561
RC1 · FY2009 · DA · contact PI
IEX-1 in bridge of innate to adaptive immune responses to memory T cells$106,110
K02 · FY2009 · AI · contact PI
IEX-1 in bridge of innate to adaptive immune responses to memory T cells$106,110
K02 · FY2008 · AI · contact PI
IEX-1 in bridge of innate to adaptive immune responses to memory T cells$106,110
K02 · FY2007 · AI · contact PI
Autoimmunity in IEX-1- transgenic mice$331,017
R01 · FY2006 · AI · contact PI
IEX-1 in bridge of innate to adaptive immune responses to memory T cells$106,110
K02 · FY2006 · AI · contact PI
Autoimmunity in IEX-1- transgenic mice$338,983
R01 · FY2005 · AI
Autoimmunity in IEX-1- transgenic mice$338,983
R01 · FY2004 · AI
Autoimmunity in IEX-1- transgenic mice$338,983
R01 · FY2003 · AI